Impacto de la pandemia COVID-19 en pacientes con enfermedades desmielinizantes

Perachino, María del Pilar; Elgani, Sofia; Siracusa, Carolina; Balbuena, María Eugenia; Nadur, Débora; Tkachuk, Verónica.
Prensa méd. argent ; 108(2): 75-81, 20220000. graf, tab
Artículo en Español | LILACS, BINACIS | ID: biblio-1368364

Documentos relacionados

  1. IL-6 Revisited: From Rheumatoid Arthritis to CAR T Cell Therapy and COVID-19.
  2. Clinical Trial Design Innovations for Precision Medicine in Asthma.
  3. COVID-19 in pregnancy and the puerperium: A review for emergency physicians.
  4. Potential application of mesenchymal stromal cells as a new therapeutic approach in acute respiratory distress syndrome and pulmonary fibrosis.
  5. Coronavirus disease (COVID-19) pandemic: an overview of systematic reviews.
  6. Convalescent plasma for people with COVID-19: a living systematic review.
  7. The COVID-19 Illness: Addressing the Current Treatment Limitations and Care Gaps with a Novel Alternative and Complementary Agent-the Glutathione-Cyclodextrin Complex.
  8. Multisystem Inflammatory Syndrome in Children (MIS-C).
  9. Pediatric anesthetic implications of COVID-19-A review of current literature.
  10. [Post-COVID syndrome-Focus fatigue].